Activity of ceftazidime (GR 20263) against nosocomially important pathogens | Zendy

J M Hamilton-Miller | Zendy; W. Brumfitt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activity of ceftazidime (GR 20263) against nosocomially important pathogens

Author(s) -

J M Hamilton-Miller,

W. Brumfitt

Publication year - 1981

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.19.6.1067

Subject(s) - ceftazidime , cefuroxime , gentamicin , antibiotics , microbiology and biotechnology , cephalosporin , bacteria , antibacterial agent , gram negative bacteria , medicine , biology , pseudomonas aeruginosa , escherichia coli , biochemistry , gene , genetics

Ceftazidime was considerably more active than cefuroxime against 180 strains of resistant species of nosocomial gram-negative bacteria. In terms of antibacterial spectrum and intrinsic activity, ceftazidime is an improvement upon existing beta-lactam antibiotics in clinical use and can be regarded as a possible alternative to gentamicin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research